Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
helen_rees [2022/06/06 16:33] liam | helen_rees [2022/12/13 17:44] (current) pamela [Sabin-Aspen Vaccine Science & Policy Group] | ||
---|---|---|---|
Line 7: | Line 7: | ||
===== Education ===== | ===== Education ===== | ||
- | Rees attended | + | Rees attended |
- | After completing her early medical training in London, she and her husband moved to Zimbabwe. She spent two years working at Harare Hospital as a registrar in pediatrics and neonatal medicine. | + | After completing her early medical training in [[united_kingdom: |
===== Career and Affiliations ===== | ===== Career and Affiliations ===== | ||
Line 15: | Line 15: | ||
==== Wits Reproductive Health and HIV Institute (1994-present) ==== | ==== Wits Reproductive Health and HIV Institute (1994-present) ==== | ||
- | Rees is the founder and executive director of the [[Wits Reproductive Health and HIV Institute]] (RHI) at the [[University of the Witwatersrand]]. | + | Rees is the founder and executive director of the [[Wits Reproductive Health and HIV Institute]] (RHI) at the [[University of the Witwatersrand]].((// |
==== African Leadership in Vaccinology Excellence ==== | ==== African Leadership in Vaccinology Excellence ==== | ||
- | Rees is a co-founder and co-director of African Leadership in Vaccinology Excellence (ALIVE), the flagship vaccinology programme at the University of the Witwatersrand. | + | Rees is a co-founder and co-director of [[African Leadership in Vaccinology Excellence]] (ALIVE), the flagship vaccinology programme at the University of the Witwatersrand.((// |
==== London School of Hygiene and Tropical Medicine ==== | ==== London School of Hygiene and Tropical Medicine ==== | ||
- | Rees is an Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine. | + | Rees is an Honorary Professor in the Department of Clinical Research at the [[London School of Hygiene and Tropical Medicine]].((//Prof Helen Rees.// The Presidency. Retrieved June 3, 2022, from https:// |
==== South Africa National Advisory Group on Immunization ==== | ==== South Africa National Advisory Group on Immunization ==== | ||
- | Rees is a member of South Africa’s National Advisory Group on Immunization. | + | Rees is a member of [[South Africa |
==== World Health Organization ==== | ==== World Health Organization ==== | ||
- | Rees plays a leadership role in several World Health Organization expert committees and initiatives: | + | Rees plays a leadership role in several |
- | * Chair of the International Health Regulations Review Committee on Polio | + | |
- | * Former chair of WHO's Strategic Advisory Group of Experts (SAGE) on Immunization | + | * Chair of the International Health Regulations Review Committee on Polio((// |
- | * STI Vaccine Roadmap Committee | + | * Former chair of WHO's Strategic Advisory Group of Experts (SAGE) on Immunization((//What is SAGE?// (2011, October 21). Wayback Machine; World Health Organization. https:// |
- | * WHO African Regional Immunization Technical Advisory Group | + | * STI Vaccine Roadmap Committee((Gottlieb, S. L., Deal, C. D., Giersing, B., Rees, H., Bolan, G., Johnston, C., Timms, P., Gray-Owen, S. D., Jerse, A. E., Cameron, C. E., Moorthy, V. S., Kiarie, J., & Broutet, N. (2016). //The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.// Vaccine, 34(26), 2939–2947. https:// |
- | * WHO Committee Developing Regulations to Cover Clinical Trials and Research During Emergencies | + | * WHO African Regional Immunization Technical Advisory Group((// |
- | * WHO Ebola Vaccine Working Group | + | * WHO Committee Developing Regulations to Cover Clinical Trials and Research During Emergencies((//Helen Rees - Founder, Director, Professor of Obstetrics and Gynecology in Johannesburg, |
- | * WHO Expert Committee on HPV Vaccines | + | * WHO Ebola Vaccine Working Group((Jasarevic, |
- | * WHO HIV Vaccine Expert Committee | + | * WHO Expert Committee on HPV Vaccines((// |
+ | * WHO HIV Vaccine Expert Committee((// | ||
==== GE2P2 Global Foundation ==== | ==== GE2P2 Global Foundation ==== | ||
- | Rees delivered a keynote presentation at the 2011 Global Vaccines 202X Access, Equity, Ethics Symposium titled WHO’s Immunization Policy Framework: Is it achieving its goal? She was introduced to the audience by Paul Offit. The symposium was hosted by the Center for Vaccine Ethics and Policy (CVEP), a program of the GE2P2 Global Foundation. Rees is a fellow of the foundation. | + | Rees delivered a keynote presentation at the 2011 [[Global Vaccines 202X Access, Equity, Ethics Symposium]] titled WHO’s Immunization Policy Framework: Is it achieving its goal?((Curry, D. R. (2011, May 16). //Symposium – Global Vaccines 202X: Access, Equity, Ethics.// Center for Vaccine Ethics and Policy. https:// |
- | The GE2P2 Global Foundation is supported by the Alliance for Regenerative Medicine, a consortium of gene therapy pharmaceutical companies including Astellas, Bristol-Myers Squibb, CRISPR Therapeutics, CSL, Fresenius Kabi, GE Healthcare, Gilead Sciences | + | |
- | ==== Population Council ==== | + | The GE2P2 Global Foundation is supported by the [[Alliance for Regenerative Medicine]], a consortium of [[gene therapy]] [[pharmaceutical companies]] including [[pharmaceutical_companies: |
- | Rees serves as a technical expert for the Population Council. The Population Council was founded by the Rockefeller family and is rooted in eugenics. Its first president, Frederick Osborn, was a former head of the American Eugenics Society. In its 1957 Annual Report, the council explains that “the Council is increasingly in a position to contribute to the understanding and so, perhaps, to the solution of problems of world population growth and change.” The council runs its Center for Biomedical Research (CBR) out of Rockefeller University in New York. | + | ==== Gavi, the Vaccine Alliance ==== |
- | The Population Council has a history | + | Rees is a member |
- | Its Board of Trustees has included representatives from AT&T, the Atomic Energy Commission, Brown University, the Carnegie Institution of Washington, Chase Manhattan Bank, Columbia-Presbyterian Medical Center, General Electric Company, Harvard University, the Milbank Memorial Fund, Mt. Sinai Hospital, the Rockefeller Institute, and Scripps Foundation for Research in Population Problems. | + | |
- | In 2015, the council convened a meeting on quality of care sponsored by the Packard Foundation, and attended by representatives from Abt Associates, Family Planning 2020, Harvard School of Public Health, Ibis Reproductive Health, ICF International, | + | |
+ | ==== Population Council ==== | ||
+ | |||
+ | Rees serves as a technical expert for the [[Population Council]].((// | ||
==== South African Health Products Regulatory Authority (SAHPRA) ==== | ==== South African Health Products Regulatory Authority (SAHPRA) ==== | ||
- | Rees is chair of the South African Health Products Regulatory Authority (SAHPRA) Board. SAHPRA is the organization in charge of regulating the use of all health products throughout South Africa, including COVID-19 vaccines. Rees oversaw the approval of the injections from Pfizer, Johnson & Johnson, and AstraZeneca. | + | Rees is chair of the [[South African Health Products Regulatory Authority]] (SAHPRA) Board.((//The SAHPRA Board.// (2022). SAHPRA. https:// |
==== National Institute of Communicable Diseases ==== | ==== National Institute of Communicable Diseases ==== | ||
- | Rees is a member of the Scientific Advisory Committee at the National Institute of Communicable Diseases. | + | Rees is a member of the Scientific Advisory Committee at the [[National Institute of Communicable Diseases]]. |
==== Coalition for Epidemic Preparedness Innovations ==== | ==== Coalition for Epidemic Preparedness Innovations ==== | ||
- | Rees is Chair of the Scientific Advisory Board of the Coalition for Epidemic Preparedness Innovations (CEPI). | + | Rees is Chair of the Scientific Advisory Board of the [[Coalition for Epidemic Preparedness Innovations]] (CEPI).((Gutierrez, |
==== International AIDS Vaccine Initiative ==== | ==== International AIDS Vaccine Initiative ==== | ||
- | Rees is a member of the Board of the International AIDS Vaccine Initiative (IAVI). | + | Rees is a member of the Board of the [[International AIDS Vaccine Initiative]] (IAVI).((// |
==== Sabin-Aspen Vaccine Science & Policy Group ==== | ==== Sabin-Aspen Vaccine Science & Policy Group ==== | ||
- | Rees is a member of the Sabin-Aspen Vaccine Science & Policy Group, an initiative of the Sabin Vaccine Institute and the Aspen Institute. The group is funded by the Bill & Melinda Gates Foundation and Wellcome Trust. | + | Rees is a member of the [[:Sabin-Aspen Vaccine Science & Policy Group]], an initiative of the S[[abin |
==== Ministerial Advisory Committee on COVID-19 and Vaccines ==== | ==== Ministerial Advisory Committee on COVID-19 and Vaccines ==== | ||
- | Rees is a member of the Ministerial Advisory Committee on COVID-19, and a member of the Ministerial Advisory Committee on COVID-19 vaccines., | + | Rees is a member of the [[Ministerial Advisory Committee on COVID-19]],((// |
==== COVID-19 Clinical Research Coalition ==== | ==== COVID-19 Clinical Research Coalition ==== | ||
- | Rees is a member of the Steering Committee of the COVID-19 Clinical Research Coalition. | + | Rees is a member of the Steering Committee of the [[COVID-19 Clinical Research Coalition]].((//Helen Rees.// COVID-19 Clinical Research Coalition. Retrieved June 3, 2022, from https:// |
- | The coalition was co-launched and is hosted by the Drugs for Neglected Diseases initiative (DNDi), which is partnered with a very large number of pharmaceutical companies including Astellas | + | |
+ | The coalition was co-launched and is hosted by the [[Drugs for Neglected Diseases initiative]] (DNDi),((// | ||
- | Other partners include the Bill & Melinda Gates Foundation, the Global Fund, Horizon 2020, Imperial College London, Institut Pasteur, London School of Hygiene and Tropical Medicine, McGill University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Pan-American Health Organization (PAHO), PATH, Rockefeller Foundation, Task Force for Global Health, UKaid, US Food and Drug Administration, | + | Other partners include the [[Bill & Melinda Gates Foundation]], the [[Global Fund]], [[Horizon 2020]], [[Imperial College London]], [[Institut Pasteur]], [[London School of Hygiene and Tropical Medicine]], [[McGill University]], [[National Institute of Allergy and Infectious Diseases]] (NIAID), |
===== Research ===== | ===== Research ===== | ||
Line 89: | Line 91: | ||
==== SOLIDARITY Trial (2020-2022) ==== | ==== SOLIDARITY Trial (2020-2022) ==== | ||
- | Rees is the Co-Chair of the South African arm of the SOLIDARITY Trial, the World Health Organization-sponsored study on repurposed drugs for use as COVID-19 treatments., | + | Rees is the Co-Chair of the South African arm of the [[SOLIDARITY Trial]], the [[World Health Organization]]-sponsored study on repurposed drugs for use as [[COVID-19 treatments]].((WHO Solidarity Trial Consortium. (2020). // |
==== CROWN CORONATION Study (2020-2022) ==== | ==== CROWN CORONATION Study (2020-2022) ==== | ||
- | Rees is a Principal Investigator for the COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION (CROWN CORONATION) study, investigating strategies to protect healthcare workers against COVID-19 infection. The study is sponsored by the COVID-19 Therapeutics Accelerator, | + | Rees is a Principal Investigator for the [[COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION]] (CROWN CORONATION) study, investigating strategies to protect healthcare workers against |
==== Additional Funding ==== | ==== Additional Funding ==== | ||
- | Rees has received funding from the Bill & Melinda Gates Foundation, Boston Consulting Group, Mary Wohlford Foundation, Microbicide Trials Network, National Institutes of Health, Public Health Institute, | + | Rees has received funding from the [[Bill & Melinda Gates Foundation]], [[Boston Consulting Group]], [[Mary Wohlford Foundation]], [[Microbicide Trials Network]], [[National Institutes of Health]], [[Public Health Institute]], [[United States |